IFRX news & sentiment — InflaRx N.V.

MAY 13·Stock TitanLow

[SCHEDULE 13G] InflaRx N.V. Passive Investment Disclosure (>5%)

TCG Crossover III entities and Chen Yu have disclosed a shared beneficial ownership of 14,500,000 Ordinary Shares in InflaRx N.V. (IFRX), representing 9.8% of the company's outstanding shares. This passive investment was reported via a SCHEDULE 13G SEC filing, indicating that the entities do not intend to influence control of the issuer. The shares outstanding figure of 147,292,859 was based on an underwritten offering concluded on May 7, 2026.

MAY 9·Moomoo

InflaRx N.V. Completes $150 Million Underwritten Offering of Ordinary Shares to Advance Pipeline Activities

InflaRx N.V. has successfully closed an underwritten public offering, raising $150 million through the sale of 11,538,460 ordinary shares at a price of $13.00 per share. This includes the full exercise of the underwriters' option to purchase additional shares. The net proceeds are intended to fund the company's ongoing clinical trials, preclinical development, and general corporate purposes.

MAY 5·TradingView

InflaRx NV expected to post a loss of 14 cents a share - Earnings Preview

InflaRx NV (IFRX) is projected to report a loss of 14 cents per share. This information comes from a Refinitiv earnings preview.

$IFRX

[SCHEDULE 13G] InflaRx N.V. Passive Investment Disclosure (>5%)

InflaRx N.V. Completes $150 Million Underwritten Offering of Ordinary Shares to Advance Pipeline Activities

InflaRx NV expected to post a loss of 14 cents a share - Earnings Preview

News on $IFRX